The Path to Reemergence

03.11.2022

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma Manufacturing on lessons learned from COVID, and the path forward to future pandemic preparedness.

Read the full article here.

CITATION

K. Langhauser, "Emergent BioSolutions: The path to reemergence," Pharma Manufacturing, February 10, 2022.

Emergent CDMO

COVID-19 In The News

03.21.2022

Four Key Considerations to Help Prepare for the Next Public Health Threat

As a CDMO, Emergent has been working for more than two decades to develop, manufacture, and deliver protections against public...

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

04.17.2020

Webinar: Finding Solutions for public health threats: COVID-19

What are innovators doing to speed up the path to treating and preventing COVID-19?

The novel coronavirus has quickly taken...